Acacia Research Corp (Nasdaq:ACTG) announced today that a subsidiary has
acquired a patent for stent graft technology.
"Acacia continues to increase the number of patent portfolios we control
in the medical device and diagnostics sectors," commented Paul Ryan,
CEO. "Acacia is expanding its presence as a leader in patent licensing
for both the technology and medical technology sectors."
ACACIA RESEARCH CORPORATION